ARCUS BIOSCIENCES INC's ticker is RCUS and the CUSIP is 03969F109. A total of 151 filers reported holding ARCUS BIOSCIENCES INC in Q4 2020. The put-call ratio across all filers is 0.76 and the average weighting 0.3%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $28,359,643 | -5.5% | 1,579,924 | +6.9% | 0.01% | 0.0% |
| Q2 2023 | $30,018,096 | +743.8% | 1,477,996 | +657.8% | 0.01% | +800.0% |
| Q1 2023 | $3,557,438 | -15.7% | 195,035 | -4.4% | 0.00% | 0.0% |
| Q4 2022 | $4,222,000 | -22.8% | 204,102 | -2.4% | 0.00% | -50.0% |
| Q3 2022 | $5,469,000 | +12.2% | 209,058 | +8.7% | 0.00% | 0.0% |
| Q2 2022 | $4,875,000 | -53.2% | 192,393 | -35.5% | 0.00% | -33.3% |
| Q3 2021 | $10,406,000 | +27.0% | 298,410 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $8,195,000 | -78.7% | 298,410 | -78.2% | 0.00% | -76.9% |
| Q1 2021 | $38,481,000 | +7.7% | 1,370,395 | -0.4% | 0.01% | 0.0% |
| Q4 2020 | $35,732,000 | – | 1,376,393 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 1,612,077 | $28,936,782 | 18.14% |
| Octagon Capital Advisors LP | 1,968,000 | $35,325,600 | 5.43% |
| Decheng Capital Management III (Cayman), LLC | 869,790 | $15,612,731 | 5.21% |
| Boxer Capital, LLC | 1,602,200 | $28,759,490 | 1.53% |
| SECTORAL ASSET MANAGEMENT INC | 375,456 | $6,739,435 | 1.31% |
| DAFNA Capital Management LLC | 222,717 | $3,997,770 | 1.24% |
| PFM Health Sciences, LP | 1,405,056 | $25,220,755 | 1.19% |
| Ikarian Capital, LLC | 4,000 | $7,180,000 | 0.86% |
| Capital Impact Advisors, LLC | 24,280 | $435,826 | 0.73% |
| Parkman Healthcare Partners LLC | 205,109 | $3,681,707 | 0.68% |